Scientists find that overexpression of USP13 is removing a tag (ubiquitin) that labels alpha-synuclein proteins in the brain for degradation - targeting USP13 both eliminated Lewy bodies and stopped them from building again (making USP13 a therapeutic target for Parkinson's etc.)

See the source article by following the link below:
Scientists find that overexpression of USP13 is removing a tag (ubiquitin) that labels alpha-synuclein proteins in the brain for degradation - targeting USP13 both eliminated Lewy bodies and stopped them from building again (making USP13 a therapeutic target for Parkinson's etc.)